These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27866006)

  • 41. The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
    Said MA; Mehta A
    Curr Urol Rep; 2018 Jun; 19(8):65. PubMed ID: 29909472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia.
    Alcántara Montero A; Müller-Arteaga C
    Actas Urol Esp (Engl Ed); 2019; 43(1):52-53. PubMed ID: 30032935
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparisons of the Efficacy and Safety of Finasteride and Dutasteride for Benign Prostatic Hyperplasia: A Network Meta-Analysis.
    Yin T; Qiao Z; Li Y; Li D; Jiang M; An C; Wang F; Zuo M; Hu K; Li Q
    Am J Ther; 2017; 24(5):e517-e523. PubMed ID: 26322675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transurethral Resection of Prostate and Bleeding: A Prospective, Randomized, Double-Blind Placebo-Controlled Trial to See the Efficacy of Short-Term Use of Finasteride and Dutasteride on Operative Blood Loss and Prostatic Microvessel Density.
    Bansal A; Arora A
    J Endourol; 2017 Sep; 31(9):910-917. PubMed ID: 28650680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of dutasteride on the risk of prostate cancer.
    Andriole GL; Bostwick DG; Brawley OW; Gomella LG; Marberger M; Montorsi F; Pettaway CA; Tammela TL; Teloken C; Tindall DJ; Somerville MC; Wilson TH; Fowler IL; Rittmaster RS;
    N Engl J Med; 2010 Apr; 362(13):1192-202. PubMed ID: 20357281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors.
    Mäkelä VJ; Kotsar A; Tammela TLJ; Murtola TJ
    J Urol; 2018 Oct; 200(4):743-748. PubMed ID: 29730200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride.
    Bird ST; Brophy JM; Hartzema AG; Delaney JA; Etminan M
    J Urol; 2013 Nov; 190(5):1811-4. PubMed ID: 23665270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adverse cardiac events in older patients receiving venlafaxine: a population-based study.
    Ho JM; Gomes T; Straus SE; Austin PC; Mamdani M; Juurlink DN
    J Clin Psychiatry; 2014 Jun; 75(6):e552-8. PubMed ID: 25004195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia].
    Botto H; Lan O; Poulain JE; Comenducci A
    Prog Urol; 2005 Dec; 15(6):1090-5. PubMed ID: 16429658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-finasteride syndrome: a surmountable challenge for clinicians.
    Traish AM
    Fertil Steril; 2020 Jan; 113(1):21-50. PubMed ID: 32033719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Finasteride versus dutasteride: a real-world economic evaluation.
    Fenter TC; Runken MC; Black L; Eaddy M
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S23-8. PubMed ID: 17295602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.
    Fenter TC; Davis EA; Shah MB; Lin PJ
    Am J Manag Care; 2008 May; 14(5 Suppl 2):S154-9. PubMed ID: 18611089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia.
    Traish AM; Haider KS; Doros G; Haider A
    Horm Mol Biol Clin Investig; 2015 Sep; 23(3):85-96. PubMed ID: 26053014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
    Issa MM; Runken MC; Grogg AL; Shah MB
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S10-6. PubMed ID: 17295600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial.
    Kaplan SA; Lee JY; Meehan AG; Kusek JW
    J Urol; 2016 Jun; 195(6):1825-9. PubMed ID: 26678956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dutasteride: a dual 5-alpha reductase inhibitor for the treatment of symptomatic benign prostatic hyperplasia.
    Dolder CR
    Ann Pharmacother; 2006 Apr; 40(4):658-65. PubMed ID: 16569804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-Effectiveness of Combination Therapy Versus Monotherapy in Benign Prostatic Hyperplasia: A Colombian Experience.
    Guevara-Cuellar CA; Parody-Rúa E; Garcia-Perdomo HA; Arenas-Duque A
    Value Health Reg Issues; 2018 Dec; 17():174-182. PubMed ID: 30415110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids.
    Othonos N; Marjot T; Woods C; Hazlehurst JM; Nikolaou N; Pofi R; White S; Bonaventura I; Webster C; Duffy J; Cornfield T; Moolla A; Isidori AM; Hodson L; Tomlinson JW
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3316-28. PubMed ID: 32594135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5α-Reductase Inhibitors for Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.
    Jun JEJ; Kinkade A; Tung ACH; Tejani AM
    Can J Hosp Pharm; 2017; 70(2):113-119. PubMed ID: 28487578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and Safety of Dutasteride in Chinese Adults with Symptomatic Benign Prostatic Hyperplasia : A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study with an Open-Label Extension.
    Na Y; Ye Z; Zhang S
    Clin Drug Investig; 2012 Jan; 32(1):29-39. PubMed ID: 27933597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.